Compare ASTS & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASTS | RMD |
|---|---|---|
| Founded | 2019 | 1989 |
| Country | United States | United States |
| Employees | 578 | 10600 |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.0B | 29.4B |
| IPO Year | N/A | N/A |
| Metric | ASTS | RMD |
|---|---|---|
| Price | $94.00 | $195.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 10 |
| Target Price | $72.10 | ★ $292.56 |
| AVG Volume (30 Days) | ★ 22.0M | 1.3M |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.13% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $167.10 | $10.60 |
| Revenue Next Year | $391.80 | $7.41 |
| P/E Ratio | ★ N/A | $25.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.25 | $180.27 |
| 52 Week High | $133.86 | $293.81 |
| Indicator | ASTS | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 47.11 | 41.11 |
| Support Level | $69.04 | N/A |
| Resistance Level | $96.49 | $260.21 |
| Average True Range (ATR) | 10.46 | 5.68 |
| MACD | -0.73 | -0.49 |
| Stochastic Oscillator | 23.81 | 47.75 |
AST SpaceMobile Inc is currently designing, developing and manufacturing the constellation of BlueBird (BB) satellites and has begun launching its planned space-based Cellular Broadband network distributed through a constellation of low Earth orbit (LEO) satellites. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.